EVALUATION OF PANBIO RAPID ANTIGEN TEST FOR SARS-CoV-2 IN SYMPTOMATIC PATIENTS AND THEIR CONTACTS: A MULTICENTER STUDY

Rapid tests to identify infectious agents can be highly useful since, in principle, they allow decisions to be made at the site of care (Point-of-Care, POC) for treatment selection, or for the separation of cohorts to avoid cross-infection. Rapid tests are especially useful in emergency situations, such as those currently being experienced in the context of the COronaVIrus Disease 19 (COVID-19) pandemic. For influenza and other respiratory viruses, rapid tests are readily available and have shown clinical benefits (Benirschke et al., 2019; Rahamat ‐Langendoen et al., 2019; Shengchen et al., 2019; Wabe et al., 2019), although not in all evaluations (Schechter-Perkins et al., 2019).

Source: International Journal of Infectious Diseases - October 19, 2021 Category: Infectious Diseases Authors: Dr. Ireri Thirion-Romero, Dr. Selene Guerrero-Z úñiga, Dr. Alexandra Arias-Mendoza, Dr. Dora Patricia Cornejo-Juárez, Dr. Patricia Meza-Meneses, Dr. Darwin Stalin Torres-Erazo, Dr. Thierry Hernández, Dr. Arturo Galindo-Fraga, Dr. Isabel Villegas-Mota, Source Type: research